HCPCS G-Codes
Procedures/Professional Services (Temporary Codes)

Temporary G codes are assigned to services and procedures that are under review before being included in the CPT coding system. Payment for these services is under the jurisdiction of the local carriers.


View All HCPCS Sections
  • G8972

    One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism
  • G8973

    Most recent hemoglobin (hgb) level < 10 g/dl
  • G8974

    Hemoglobin level measurement not documented, reason not given
  • G8975

    Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)
  • G8976

    Most recent hemoglobin (hgb) level >= 10 g/dl
  • G8977

    I intend to report the oncology measures group
  • G8978

    Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals
  • G8979

    Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • G8980

    Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting
  • G8981

    Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals
  • G8982

    Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • G8983

    Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting
  • G8984

    Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals
  • G8985

    Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • G8986

    Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting
  • G8987

    Self care functional limitation, current status, at therapy episode outset and at reporting intervals
  • G8988

    Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • G8989

    Self care functional limitation, discharge status, at discharge from therapy or to end reporting
  • G8990

    Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals
  • G8991

    Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • G8992

    Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting
  • G8993

    Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals
  • G8994

    Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • G8995

    Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting
  • G8996

    Swallowing functional limitation, current status at therapy episode outset and at reporting intervals
  • G8997

    Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
  • G8998

    Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting
  • G8999

    Motor speech functional limitation, current status at therapy episode outset and at reporting intervals
  • G9001

    Coordinated care fee, initial rate
  • G9002

    Coordinated care fee, maintenance rate
  • G9003

    Coordinated care fee, risk adjusted high, initial
  • G9004

    Coordinated care fee, risk adjusted low, initial
  • G9005

    Coordinated care fee, risk adjusted maintenance
  • G9006

    Coordinated care fee, home monitoring
  • G9007

    Coordinated care fee, scheduled team conference
  • G9008

    Coordinated care fee, physician coordinated care oversight services
  • G9009

    Coordinated care fee, risk adjusted maintenance, level 3
  • G9010

    Coordinated care fee, risk adjusted maintenance, level 4
  • G9011

    Coordinated care fee, risk adjusted maintenance, level 5
  • G9012

    Other specified case management service not elsewhere classified
  • G9013

    Esrd demo basic bundle level i
  • G9014

    Esrd demo expanded bundle including venous access and related services
  • G9016

    Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]
  • G9017

    Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)
  • G9018

    Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)
  • G9019

    Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)
  • G9020

    Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)
  • G9033

    Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)
  • G9034

    Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)
  • G9035

    Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/25/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.